| Amber Rose Stutzman, FNP-C | |
|
101 E Park Dr, Albion, IN 46701-1438 | |
| (260) 636-6684 | |
| Not Available |
| Full Name | Amber Rose Stutzman |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 3 Years |
| Location | 101 E Park Dr, Albion, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811566169 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 71011437A (Indiana) | Primary |
| 207Q00000X | Family Medicine | F06211568 (Indiana) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Otis R Bowen Center For Human Services Inc | 7618950965 | 39 |
News Archive
A disposal, plastic listening device that attaches to the abdomen may help doctors definitively determine which post-operative patients should be fed and which should not, an invention that may improve outcomes, decrease healthcare costs and shorten hospital stays, according to a UCLA study.
For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration's definition of bioequivalence as it applies to narrow therapeutic index drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.
› Verified 5 days ago
| Entity Name | The Otis R Bowen Center For Human Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639172810 PECOS PAC ID: 7618950965 Enrollment ID: O20050404000853 |
News Archive
A disposal, plastic listening device that attaches to the abdomen may help doctors definitively determine which post-operative patients should be fed and which should not, an invention that may improve outcomes, decrease healthcare costs and shorten hospital stays, according to a UCLA study.
For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration's definition of bioequivalence as it applies to narrow therapeutic index drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amber Rose Stutzman, FNP-C Po Box 821, Kendallville, IN 46755 Ph: (260) 318-5739 | Amber Rose Stutzman, FNP-C 101 E Park Dr, Albion, IN 46701-1438 Ph: (260) 636-6684 |
News Archive
A disposal, plastic listening device that attaches to the abdomen may help doctors definitively determine which post-operative patients should be fed and which should not, an invention that may improve outcomes, decrease healthcare costs and shorten hospital stays, according to a UCLA study.
For several years, epilepsy practitioners have questioned the U.S. Food and Drug Administration's definition of bioequivalence as it applies to narrow therapeutic index drugs, such as those used for epilepsy. In response to these concerns, the FDA has sponsored 3 studies of antiepileptic drugs and also convened an advisory board to help determine which drugs are NTI.
IDEXX Laboratories, Inc., announced today that its Board of Directors has authorized the repurchase by the Company of up to an additional four million shares of its common stock under its ongoing share repurchase program.
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have determined a key mechanism by which Bacillus anthracis bacteria initiate anthrax infection despite being greatly outnumbered by immune system scavenger cells. The finding, made by studying genetically modified mice, adds new detail to the picture of early-stage anthrax infection and supports efforts to develop vaccines and drugs that would block this part of the cycle.
› Verified 5 days ago
Wendy Bodwell, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 833 E Main St, Albion, IN 46701 Phone: 260-636-6975 | |
Amy Wargowsky, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 101 E Park Dr, Albion, IN 46701 Phone: 260-636-6884 | |
Ms. Kedisha Ruchel Gardener, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 600 Trail Ridge Rd, Albion, IN 46701 Phone: 260-440-0168 |